How is the Aeglea BioTherapeutics Inc today?

The Aeglea BioTherapeutics Inc today is trading in the down by -0.66% at 15.08.

How has Aeglea BioTherapeutics Inc performed historically?

The Aeglea BioTherapeutics Inc is currently trading down -0.66% on an intraday basis in the past week the index fell -16.22%. The index has been down -0.66% in the past quarter and fell -0.66% in the past year. You can view this in the overview section.

What is Aeglea BioTherapeutics Inc Annual Revenue?

Aeglea BioTherapeutics Inc Annual Revenue fell 87.57%, in the last year to $2.33 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Aeglea BioTherapeutics Inc Annual Net Profit?

Aeglea BioTherapeutics Inc Annual Net Profit fell 27.38% in the last year to $83.82 M. Its sector's average net profit growth for the last fiscal year was -14.04%.

What is Aeglea BioTherapeutics Inc Price to Earning Ratio?

Aeglea BioTherapeutics Inc Price to Earning Ratio is -0.21, which is negative.

What is Aeglea BioTherapeutics Inc Stock Price?

Aeglea BioTherapeutics Inc Stock Price fell 0.66% and underperformed its sector by 427.75% in the past year.

What is Aeglea BioTherapeutics Inc Quarterly Net profit?

Aeglea BioTherapeutics Inc Quarterly Net profit fell 119.96% YoY to $40.11 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Aeglea BioTherapeutics Inc Debt to Equity Ratio?

Aeglea BioTherapeutics Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Aeglea BioTherapeutics Inc Return on Equity(ROE)?

Aeglea BioTherapeutics Inc Return on Equity(ROE) for the last financial year was -124.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Aeglea BioTherapeutics Inc Mutual Fund Holding?

Aeglea BioTherapeutics Inc Mutual Fund Holding increased by 5.9% in the last quarter to 9.93.

What is Aeglea BioTherapeutics Inc Institutional Holding?

Aeglea BioTherapeutics Inc Institutional Holding increased by 63.12% in the last quarter to 9.1.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
AEGLEA BIOTHERAPEUTICS INC

Aeglea BioTherapeutics Inc XNAS: AGLE

Aeglea BioTherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Aeglea BioTherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aeglea BioTherapeutics Inc
Rating: 1.30450
Author: Trendlyne DVM scores

about

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

15.08 -0.10 (-0.66%)

New 52W Low in past week

597.0K

XNAS Volume

XNAS 18 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.5 / 100

Technically Neutral

43.7 / 100

No estimates available

Aeglea BioTherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aeglea BioTherapeutics Inc Live Share Price Today, Share Analysis and Chart

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

New 52W Low in past week

SWOT Analysis

Aeglea BioTherapeutics Inc Live Price Chart

Aeglea BioTherapeutics Inc FAQ

How is Aeglea BioTherapeutics Inc today?

Aeglea BioTherapeutics Inc today is trading in the red, and is down by -0.66% at 15.08.

How has Aeglea BioTherapeutics Inc performed historically?

Aeglea BioTherapeutics Inc is currently trading down -0.66% on an intraday basis. In the past week the stock fell -16.22%. stock has been down -0.66% in the past quarter and fell -0.66% in the past year. You can view this in the overview section.